• Explore /
  • Poster
  • / Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).

Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).

Abstract Poster

Authors

null

David M. Cognetti

Thomas Jefferson University Hospital, Philadelphia, PA

David M. Cognetti , Jennifer Maria Johnson , Joseph M. Curry , Frank Mott , Samith Thomas Kochuparambil , Darren McDonald , Mary J. Fidler , Kerstin Stenson , Nilesh R. Vasan , Mohammad Razaq , John P. Campana , Merrill A. Biel , Ann M. Gillenwater

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT02422979

Citation

J Clin Oncol 37, 2019 (suppl; abstr 6014)

DOI

10.1200/JCO.2019.37.15_suppl.6014

Abstract #

6014

Poster Bd #

3

Abstract Disclosures

Similar Posters

First Author: Ann M. Gillenwater

First Author: Christine H. Chung

First Author: Merrill A. Biel

First Author: Liqiong Xue